PCI BIOTECH HLD
PCI BIOTECH HLD operates in Diversified Metals & Mining.
Market Cap & Net Worth: PCI BIOTECH HLD (4QG)
PCI BIOTECH HLD (BE:4QG) has a market capitalization of $274.39 (€267.32) as of March 19, 2026. Listed on the BE stock exchange, this Germany-based company holds position #49440 globally and #8319 in its home market, demonstrating a 30.97% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PCI BIOTECH HLD's stock price €0.03 by its total outstanding shares 9031 (9.03K).
PCI BIOTECH HLD Market Cap History: 2015 to 2025
PCI BIOTECH HLD's market capitalization history from 2015 to 2025. Data shows change from $4.13K to $274.39 (-23.47% CAGR).
PCI BIOTECH HLD Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PCI BIOTECH HLD's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 4QG by Market Capitalization
Companies near PCI BIOTECH HLD in the global market cap rankings as of March 19, 2026.
Key companies related to PCI BIOTECH HLD by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
PCI BIOTECH HLD Historical Marketcap From 2015 to 2025
Between 2015 and today, PCI BIOTECH HLD's market cap moved from $4.13K to $ 274.39, with a yearly change of -23.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €274.39 | -71.26% |
| 2024 | €954.82 | -44.62% |
| 2023 | €1.72K | -2.72% |
| 2022 | €1.77K | -86.25% |
| 2021 | €12.89K | -46.60% |
| 2020 | €24.15K | -64.39% |
| 2019 | €67.81K | +194.96% |
| 2018 | €22.99K | -39.34% |
| 2017 | €37.90K | +169.31% |
| 2016 | €14.07K | +241.15% |
| 2015 | €4.13K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of PCI BIOTECH HLD was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $274.39 USD |
| MoneyControl | $274.39 USD |
| MarketWatch | $274.39 USD |
| marketcap.company | $274.39 USD |
| Reuters | $274.39 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.